|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.33 USD | -1.67% |
|
-0.58% | -0.04% |
| 01-13 | Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says | RE |
| 01-12 | ServiceNow, Inc. : The Control Layer of the Enterprise AI Stack |  |
| Capitalization | 101B 86.41B 80.46B 74.87B 140B 9,091B 151B 925B 364B 4,349B 378B 370B 15,935B | P/E ratio 2025 * |
-285x | P/E ratio 2026 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise value | 161B 138B 129B 120B 223B 14,534B 241B 1,479B 582B 6,953B 604B 591B 25,476B | EV / Sales 2025 * |
0.4x | EV / Sales 2026 * | 0.38x |
| Free-Float |
70.66% | Yield 2025 * |
3.48% | Yield 2026 * | 3.58% |
Last Transcript: CVS Health Corporation
| 1 day | -1.67% | ||
| 1 week | -0.58% | ||
| Current month | -0.04% | ||
| 1 month | -0.11% | ||
| 3 months | -0.41% | ||
| 6 months | +23.26% | ||
| Current year | -0.04% |
| 1 week | 78.98 |  | 81.16 |
| 1 month | 77.02 | | 81.76 |
| Current year | 78.22 | | 81.76 |
| 1 year | 50.63 | | 85.15 |
| 3 years | 43.56 | | 90.62 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 17/10/2024 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 12/05/2025 |
David Falkowski
CMP | Compliance Officer | - | 01/07/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 01/03/2007 |
Anne Finucane
BRD | Director/Board Member | 73 | 20/01/2011 |
| Director/Board Member | 71 | 05/03/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.01% | 3.92% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.67% | -0.58% | +53.83% | -11.78% | 101B | |
| -0.10% | +1.74% | +56.59% | +84.97% | 109B | |
| -2.37% | +2.03% | +43.43% | +77.79% | 34.12B | |
| -0.69% | +4.81% | -13.19% | +16.95% | 24.3B | |
| +3.16% | +3.26% | +11.73% | +4.09% | 21.72B | |
| +3.78% | +4.84% | +22.09% | +26.25% | 20.78B | |
| -2.01% | -3.37% | +52.93% | +277.32% | 17.15B | |
| +0.30% | -1.59% | +54.15% | +53.38% | 16.55B | |
| 0.00% | -5.54% | -16.65% | +8.57% | 12.04B | |
| -1.28% | -4.40% | +8.18% | +34.72% | 12.45B | |
| Average | -0.06% | +0.61% | +27.31% | +57.23% | 36.91B | |
| Weighted average by Cap. | -0.45% | +1.20% | +41.14% | +48.70% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 400B 343B 320B 297B 555B 36,121B 598B 3,675B 1,446B 17,279B 1,501B 1,470B 63,314B | 410B 352B 328B 305B 569B 37,005B 613B 3,765B 1,481B 17,702B 1,537B 1,506B 64,863B |
| Net income | -162M -139M -130M -121M -225M -14.65B -243M -1.49B -586M -7.01B -609M -596M -25.68B | 7.35B 6.31B 5.88B 5.47B 10.2B 664B 11B 67.56B 26.58B 318B 27.58B 27.01B 1,164B |
| Net Debt | 60.29B 51.74B 48.17B 44.83B 83.66B 5,443B 90.18B 554B 218B 2,604B 226B 221B 9,541B | 55.47B 47.6B 44.32B 41.24B 76.96B 5,008B 82.97B 510B 200B 2,395B 208B 204B 8,778B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/01/26 | 79.33 $ | -1.67% | 4,488,050 |
| 13/01/26 | 80.68 $ | +0.40% | 8,095,232 |
| 12/01/26 | 80.36 $ | +0.07% | 7,400,955 |
| 09/01/26 | 80.30 $ | -0.37% | 7,968,732 |
| 08/01/26 | 80.60 $ | +1.02% | 7,176,498 |
Delayed Quote Nyse, January 15, 2026 at 05:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition